GlobeNewswire: Sientra, Inc. Contains the last 10 of 187 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T08:47:17ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2024/02/13/2828253/0/en/Sientra-to-Pursue-Strategic-Sale-of-its-Business-Through-Voluntary-Chapter-11-Process.html?f=22&fvtc=4&fvtv=23916Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process2024-02-13T13:30:00Z<![CDATA[Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale process Company secures $22.5 million of new money in debtor-in-possession financing from existing lenders to support ongoing operations during the sale process]]>https://www.globenewswire.com/news-release/2023/11/09/2777817/0/en/Sientra-Reports-Third-Quarter-Financial-and-Operational-Results.html?f=22&fvtc=4&fvtv=23916Sientra Reports Third Quarter Financial and Operational Results2023-11-09T21:05:00Z<![CDATA[IRVINE, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its financial results for the third quarter that ended September 30, 2023.]]>https://www.globenewswire.com/news-release/2023/11/08/2776277/0/en/Sientra-to-Present-at-the-Stifel-2023-Healthcare-Conference.html?f=22&fvtc=4&fvtv=23916Sientra to Present at the Stifel 2023 Healthcare Conference2023-11-08T13:35:00Z<![CDATA[IRVINE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced its participation at the Stifel 2023 Healthcare Conference. As part of the conference, the company’s management team will participate in a live fireside chat on Wednesday, November 15, 2023 at 8:00am EST / 5:00am PST.]]>https://www.globenewswire.com/news-release/2023/10/30/2769738/0/en/Sientra-Reports-Preliminary-Unaudited-Third-Quarter-2023-Financial-Results-and-Provides-Update-on-Outlook.html?f=22&fvtc=4&fvtv=23916Sientra Reports Preliminary Unaudited Third Quarter 2023 Financial Results and Provides Update on Outlook2023-10-30T21:00:51Z<![CDATA[IRVINE, Calif., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a surgical aesthetics company delivering the safest and most innovative solutions for the best outcomes, today announced preliminary unaudited financial results for the fiscal third quarter ended September 30, 2023.]]>https://www.globenewswire.com/news-release/2023/08/10/2723122/0/en/Sientra-Reports-Record-Second-Quarter-Financial-and-Operational-Results.html?f=22&fvtc=4&fvtv=23916Sientra Reports Record Second Quarter Financial and Operational Results2023-08-10T20:03:00Z<![CDATA[Revenue growth of 7.5% driven by continued market share gains in reconstruction and augmentation]]>https://www.globenewswire.com/news-release/2023/07/27/2711870/0/en/Sientra-to-Report-Second-Quarter-2023-Financial-Results-on-August-10-2023.html?f=22&fvtc=4&fvtv=23916Sientra to Report Second Quarter 2023 Financial Results on August 10, 20232023-07-27T08:05:00Z<![CDATA[IRVINE, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN)(“Sientra” or the “Company”), a medical aesthetics company developing the safest and most innovative solutions for the best aesthetic outcomes, today announced that it will release financial results for the second quarter of 2023 after the close of trading on Thursday, August 10, 2023. Sientra will host a conference call to discuss financial results the same day at 4:30 p.m. Eastern Time.]]>https://www.globenewswire.com/news-release/2023/06/30/2698097/0/en/Sientra-Reports-Inducement-Grants-Under-NASDAQ-Listing-Rule-5635-c-4.html?f=22&fvtc=4&fvtv=23916Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)2023-06-30T20:42:01Z<![CDATA[IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced that on June 27, 2023, the Company approved equity award grants under the Sientra Inc. Inducement Plan to 20 new employees.]]>https://www.globenewswire.com/news-release/2023/06/20/2691098/0/en/Sientra-Announces-Appointment-of-Alexander-W-Casdin-to-Board-of-Directors.html?f=22&fvtc=4&fvtv=23916Sientra Announces Appointment of Alexander W. Casdin to Board of Directors2023-06-20T12:35:00Z<![CDATA[IRVINE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, announced the appointment of Alexander W. Casdin to the Company’s Board of Directors, effective June 15, 2023.]]>https://www.globenewswire.com/news-release/2023/06/08/2685191/0/en/Sientra-Announces-FDA-Clearance-of-Next-Generation-AlloX2-Pro-Tissue-Expander.html?f=22&fvtc=4&fvtv=23916Sientra Announces FDA-Clearance of Next Generation AlloX2 Pro™ Tissue Expander2023-06-08T20:05:00Z<![CDATA[Significant Milestone as the First, and Only, MRI-Compatible Tissue Expander Available on the US Market]]>https://www.globenewswire.com/news-release/2023/05/17/2671010/0/en/Sientra-Announces-FDA-Clearance-of-Novel-Portfinder-Technology.html?f=22&fvtc=4&fvtv=23916Sientra Announces FDA-Clearance of Novel Portfinder™ Technology2023-05-17T12:30:28Z<![CDATA[Continued Innovation Showcases Sientra’s Leadership in Reconstruction Surgeries Continued Innovation Showcases Sientra’s Leadership in Reconstruction Surgeries]]>